19.45
+0.20
+(1.04%)
At close: 1:30:39 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
368,524.00
318,015.00
368,546.00
427,929.00
325,191.00
Cost of Revenue
124,633.00
106,823.00
111,829.00
128,603.00
109,801.00
Gross Profit
243,891.00
211,192.00
256,717.00
299,326.00
215,390.00
Operating Expense
201,270.00
203,467.00
196,535.00
170,989.00
145,030.00
Operating Income
42,621.00
7,725.00
60,182.00
128,337.00
70,360.00
Net Non Operating Interest Income Expense
8,453.00
7,551.00
4,049.00
1,246.00
1,231.00
Pretax Income
57,953.00
28,163.00
66,258.00
139,424.00
76,847.00
Tax Provision
14,720.00
5,732.00
18,797.00
29,823.00
16,632.00
Net Income Common Stockholders
53,144.00
32,991.00
56,978.00
113,132.00
60,884.00
Diluted NI Available to Com Stockholders
53,144.00
32,991.00
56,978.00
113,132.00
60,884.00
Basic EPS
0.61
0.38
0.66
1.31
0.69
Diluted EPS
0.61
0.38
0.66
1.30
0.69
Basic Average Shares
87,022.09
86,418.00
86,371.00
86,357.00
87,797.00
Diluted Average Shares
87,022.09
86,570.00
86,660.00
86,741.00
88,058.00
Total Expenses
325,903.00
310,290.00
308,364.00
299,592.00
254,831.00
Net Income from Continuing & Discontinued Operation
53,144.00
32,991.00
56,978.00
113,132.00
60,884.00
Normalized Income
50,833.63
33,578.00
55,697.24
115,724.55
60,371.55
Interest Income
11,515.00
8,524.00
4,804.00
2,012.00
2,037.00
Interest Expense
3,062.00
973.00
755.00
766.00
806.00
Net Interest Income
8,453.00
7,551.00
4,049.00
1,246.00
1,231.00
EBIT
61,015.00
29,136.00
67,013.00
140,190.00
77,653.00
EBITDA
132,541.00
93,916.00
117,428.00
161,324.00
98,526.00
Reconciled Cost of Revenue
124,633.00
106,823.00
111,829.00
128,603.00
109,801.00
Reconciled Depreciation
71,526.00
64,780.00
50,415.00
21,134.00
20,873.00
Net Income from Continuing Operation Net Minority Interest
53,144.00
32,991.00
56,978.00
113,132.00
60,884.00
Total Unusual Items Excluding Goodwill
3,097.00
-737.00
1,788.00
-3,298.00
654.00
Total Unusual Items
3,097.00
-737.00
1,788.00
-3,298.00
654.00
Normalized EBITDA
129,444.00
94,653.00
115,640.00
164,622.00
97,872.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
786.63
-150.00
507.24
-705.45
141.55
12/31/2020 - 9/19/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1762.TW Chunghwa Chemical Synthesis & Biotech Co., Ltd.
33.20
+0.30%
1733.TW Apex Biotechnology Corp.
29.95
0.00%
1734.TW Sinphar Pharmaceutical Co.,Ltd.
30.75
+0.33%
6885.TW BRIM Biotechnology, Inc.
28.90
-2.03%
4133.TW Abnova (Taiwan) Corporation
29.80
-1.16%
3118.TWO Level Biotechnology Inc.
32.35
-0.15%
1760.TW Panion & Bf Biotech Inc.
82.70
+1.10%
4131.TWO NeoCore Technology Co., Ltd.
31.00
0.00%
3205.TWO Sagittarius Life Science Corp
33.95
-1.59%
6838.TW Formosa Pharmaceuticals, Inc.
34.00
-0.73%